Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BF2.649 (pitolisant) for excessive daytime sleepiness in Parkinson's disease
2009-013886-24Phase 3Completed
- Sponsor
- Bioprojet
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Parkinson's disease (PD) and Excessive Daytime Sleepiness (EDS) comparing Pitolisant with Placebo (2 arms). Primary endpoint: Change in Epworth Sleepiness Scale score at Week 12. Started Oct 2009; status: completed.
02
Drugs
pitolisant
03
Conditions
Parkinson's disease (PD)Excessive Daytime Sleepiness (EDS)
Beyond the preview
Go deeper on 2009-013886-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013886-24.